{
  "pmid": "19949062",
  "uid": "19949062",
  "title": "Detection and characterization of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates in Canada: results from the Canadian Nosocomial Infection Surveillance Program, 1995-2006.",
  "abstract": "We describe the epidemiology of heterogeneously resistant Staphylococcus aureus (hVISA) identified in Canadian hospitals between 1995 and 2006. hVISA isolates were confirmed by the population analysis profiling-area under the curve method. Only 25 hVISA isolates (1.3% of all isolates) were detected. hVISA isolates were more likely to have been health care associated (odds ratio [OR], 5.1; 95% confidence interval [CI], 1.9 to 14.2) and to have been recovered from patients hospitalized in central Canada (OR, 3.0; 95% CI, 1.2 to 7.4). There has been no evidence of vancomycin \"MIC creep\" in Canadian strains of methicillin (meticillin)-resistant S. aureus, and hVISA strains are currently uncommon.",
  "authors": [
    {
      "last_name": "Adam",
      "fore_name": "Heather J",
      "initials": "HJ",
      "name": "Heather J Adam",
      "affiliations": [
        "Department of Laboratory Medicine & Pathobiology, University of Toronto, and Hospital for Sick Children, Toronto, Ontario, Canada."
      ]
    },
    {
      "last_name": "Louie",
      "fore_name": "Lisa",
      "initials": "L",
      "name": "Lisa Louie",
      "affiliations": []
    },
    {
      "last_name": "Watt",
      "fore_name": "Christine",
      "initials": "C",
      "name": "Christine Watt",
      "affiliations": []
    },
    {
      "last_name": "Gravel",
      "fore_name": "Denise",
      "initials": "D",
      "name": "Denise Gravel",
      "affiliations": []
    },
    {
      "last_name": "Bryce",
      "fore_name": "Elizabeth",
      "initials": "E",
      "name": "Elizabeth Bryce",
      "affiliations": []
    },
    {
      "last_name": "Loeb",
      "fore_name": "Mark",
      "initials": "M",
      "name": "Mark Loeb",
      "affiliations": []
    },
    {
      "last_name": "Matlow",
      "fore_name": "Anne",
      "initials": "A",
      "name": "Anne Matlow",
      "affiliations": []
    },
    {
      "last_name": "McGeer",
      "fore_name": "Allison",
      "initials": "A",
      "name": "Allison McGeer",
      "affiliations": []
    },
    {
      "last_name": "Mulvey",
      "fore_name": "Michael R",
      "initials": "MR",
      "name": "Michael R Mulvey",
      "affiliations": []
    },
    {
      "last_name": "Simor",
      "fore_name": "Andrew E",
      "initials": "AE",
      "name": "Andrew E Simor",
      "affiliations": []
    },
    {
      "affiliations": []
    }
  ],
  "journal": {
    "title": "Antimicrobial agents and chemotherapy",
    "iso_abbreviation": "Antimicrob Agents Chemother",
    "issn": "1098-6596",
    "issn_type": "Electronic",
    "volume": "54",
    "issue": "2",
    "pub_year": "2010",
    "pub_month": "Feb"
  },
  "start_page": "945",
  "end_page": "949",
  "pages": "945-9",
  "language": "eng",
  "publication_types": [
    "Journal Article",
    "Research Support, Non-U.S. Gov't"
  ],
  "keywords": [
    "Anti-Bacterial Agents",
    "Canada",
    "Cross Infection",
    "Drug Resistance, Multiple, Bacterial",
    "Methicillin-Resistant Staphylococcus aureus",
    "Microbial Sensitivity Tests",
    "Staphylococcal Infections",
    "Vancomycin",
    "Vancomycin Resistance"
  ],
  "article_ids": {
    "pubmed": "19949062",
    "pmc": "PMC2812162",
    "doi": "10.1128/AAC.01316-09",
    "pii": "AAC.01316-09"
  },
  "doi": "10.1128/AAC.01316-09",
  "pmc_id": "PMC2812162",
  "dates": {
    "completed": "2010-03-04",
    "revised": "2021-10-20"
  },
  "chemicals": [
    "Anti-Bacterial Agents",
    "Vancomycin"
  ],
  "grants": [],
  "search_metadata": {
    "search_type": "all_publications",
    "retrieved_date": "2025-07-30T14:39:51.169879",
    "pmid": "19949062"
  }
}